IPO Market Gains Traction in the 2Q Despite Tariff Turmoil Despite an early surge in volatility from shifting US tariff policies and recession concerns, the IPO market ended the quarter with more momentum than it started. A total of 44 IPOs raised a combined...read more
A handful of IPOs and blank checks priced in the short holiday week, led by two sizable issuers. Precision medicine platform Caris Life Sciences (CAI) priced above the upwardly revised range to raise $494 million at a $6.1 billion market cap. Caris is...read more
Slide Insurance Holdings, a home insurance provider focused on the coastal southern US, raised $408 million by offering 24 million shares (31% from insiders) at $17, the high end of the range of $15 to $17. The company sold 20% more shares than expected, with...read more
Two sizable IPOs are scheduled to price in the short holiday week ahead. Precision medicine platform Caris Life Sciences (CAI) plans to raise $400 million at a $5.2 billion market cap. The company is developing and commercializing a platform combining...read more
Updated: Renaissance Capital's 2Q 2025 US IPO Market Review
IPO Market Gains Traction in the 2Q Despite Tariff Turmoil Despite an early surge in volatility from shifting US tariff policies and recession concerns, the IPO market ended the quarter with more momentum than it started. A total of 44 IPOs raised a combined...read more
US IPO Weekly Recap: Sizable precision medicine and insurance IPOs raise a combined $902 million
A handful of IPOs and blank checks priced in the short holiday week, led by two sizable issuers. Precision medicine platform Caris Life Sciences (CAI) priced above the upwardly revised range to raise $494 million at a $6.1 billion market cap. Caris is...read more
Slide prices upsized IPO at $17, the high end of the range
Slide Insurance Holdings, a home insurance provider focused on the coastal southern US, raised $408 million by offering 24 million shares (31% from insiders) at $17, the high end of the range of $15 to $17. The company sold 20% more shares than expected, with...read more
US IPO Week Ahead: Precision medicine and insurance IPOs take on the short holiday week
Two sizable IPOs are scheduled to price in the short holiday week ahead. Precision medicine platform Caris Life Sciences (CAI) plans to raise $400 million at a $5.2 billion market cap. The company is developing and commercializing a platform combining...read more